Ceres Ventures ROA 2010-2011 | CEVE
Current and historical return on assets (ROA) values for Ceres Ventures (CEVE) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Ceres Ventures ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2011-09-30 | $0.00B | $0.00B | 0.00% |
| 2011-06-30 | $0.00B | $0.00B | 0.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | 0.00% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| 2010-03-31 | $0.00B | $0.00B | 0.00% |
| 2009-12-31 | $0.00B | $0.00B | 400.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.000B |
| Ceres Ventures, Inc. is an investment company. The company does not have any significant operation. Ceres Ventures, Inc., formerly known as PhytoMedical Technologies Inc., is based in Princeton, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $18.282B | 18.36 |
| DaVita (DVA) | United States | $11.202B | 14.29 |
| Encompass Health (EHC) | United States | $10.408B | 23.33 |
| Chemed (CHE) | United States | $8.501B | 27.28 |
| Option Care Health (OPCH) | United States | $5.259B | 25.21 |
| Elanco Animal Health (ELAN) | United States | $4.190B | 9.27 |
| RadNet (RDNT) | United States | $3.686B | 79.02 |
| Amedisys (AMED) | United States | $3.011B | 21.29 |
| LifeStance Health (LFST) | United States | $2.576B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.840B | 21.32 |
| Astrana Health (ASTH) | United States | $1.573B | 35.26 |
| U.S Physical Therapy (USPH) | United States | $1.025B | 26.14 |
| Pennant (PNTG) | United States | $0.907B | 36.29 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.886B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.294B | 0.00 |
| Daxor (DXR) | United States | $0.036B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.004B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |